PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 38 filers reported holding PSYCHEMEDICS CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $329,000 | +30.6% | 13,349 | +5.2% | 0.00% | – |
| Q3 2016 | $252,000 | +39.2% | 12,691 | -3.8% | 0.00% | – |
| Q2 2016 | $181,000 | -33.0% | 13,197 | -32.9% | 0.00% | – |
| Q1 2016 | $270,000 | +25.0% | 19,660 | -7.7% | 0.00% | – |
| Q4 2015 | $216,000 | +2.9% | 21,291 | +1.9% | 0.00% | – |
| Q3 2015 | $210,000 | -28.1% | 20,896 | +6.2% | 0.00% | – |
| Q2 2015 | $292,000 | -18.9% | 19,682 | -9.3% | 0.00% | – |
| Q1 2015 | $360,000 | +2.6% | 21,705 | -6.4% | 0.00% | – |
| Q4 2014 | $351,000 | +15.1% | 23,177 | +7.7% | 0.00% | – |
| Q3 2014 | $305,000 | -6.7% | 21,521 | -6.8% | 0.00% | – |
| Q2 2014 | $327,000 | -14.8% | 23,085 | +2.9% | 0.00% | – |
| Q1 2014 | $384,000 | +21.9% | 22,435 | +4.6% | 0.00% | – |
| Q4 2013 | $315,000 | +15.8% | 21,450 | +4.4% | 0.00% | – |
| Q3 2013 | $272,000 | +44.7% | 20,550 | +17.2% | 0.00% | – |
| Q2 2013 | $188,000 | – | 17,530 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 274,418 | $1,089,439 | 0.78% |
| WEALTH EFFECTS LLC | 40,701 | $161,582 | 0.08% |
| Cannell Capital | 74,794 | $296,932 | 0.07% |
| SANTA MONICA PARTNERS LP | 20,000 | $79 | 0.06% |
| RBF Capital, LLC | 144,231 | $572,597 | 0.04% |
| WEDBUSH SECURITIES INC | 42,414 | $168 | 0.01% |
| Ancora Advisors LLC | 78,373 | $311,141 | 0.01% |
| Your Advocates Ltd., LLP | 1,400 | $5,558 | 0.00% |
| CRAWFORD INVESTMENT COUNSEL INC | 32,098 | $127,428 | 0.00% |
| Renaissance Technologies | 273,663 | $1,086 | 0.00% |